{"id":"vasopressin-arginine","safety":{"commonSideEffects":[{"rate":null,"effect":"Vasoconstriction/ischemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Abdominal cramping"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Tremor"}]},"_chembl":{"chemblId":"CHEMBL3229641","moleculeType":"Protein","molecularWeight":"1098.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Arginine vasopressin (AVP) acts as a potent vasoconstrictor by activating V1 receptors on vascular smooth muscle, thereby increasing systemic vascular resistance and blood pressure. It also binds to V2 receptors in the kidney's collecting duct to increase aquaporin-2 water channel expression, promoting water reabsorption and reducing urine output. Additionally, vasopressin enhances hemostasis by promoting release of von Willebrand factor and factor VIII from endothelial cells.","oneSentence":"Arginine vasopressin is a peptide hormone that binds to vasopressin receptors to increase blood pressure, promote water reabsorption in the kidneys, and enhance blood clotting.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:14:52.379Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Variceal bleeding (esophageal varices)"},{"name":"Diabetes insipidus"},{"name":"Hypotension/shock"},{"name":"Hemophilia A and von Willebrand disease"}]},"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT06426407","phase":"","title":"Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2025-10-01","conditions":"Shock, Septic","enrollment":2},{"nctId":"NCT07276152","phase":"NA","title":"Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-01-09","conditions":"Sonic Augmentation Technology","enrollment":22},{"nctId":"NCT06344442","phase":"PHASE3","title":"Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-16","conditions":"Acute Kidney Injury Post Liver Transplantation","enrollment":304},{"nctId":"NCT05190744","phase":"PHASE2","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-09-01","conditions":"Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus","enrollment":36},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06542198","phase":"NA","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-09-10","conditions":"Polyuria-polydipsia Syndrome, Arginine Vasopressin Deficiency, Primary Polydipsia","enrollment":42},{"nctId":"NCT06635629","phase":"PHASE2","title":"Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-12-12","conditions":"Cushing Syndrome","enrollment":140},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT04789148","phase":"PHASE1","title":"Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2025-09-10","conditions":"Vasopressin Deficiency","enrollment":40},{"nctId":"NCT06622187","phase":"PHASE4","title":"Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-08-14","conditions":"Bleeding, Transplant, Kidney, Desmopressin","enrollment":96},{"nctId":"NCT06821802","phase":"NA","title":"Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-04-14","conditions":"Hyponatremia, Syndrome of Inappropriate Antidiuresis","enrollment":70},{"nctId":"NCT06020495","phase":"PHASE3","title":"Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-12-17","conditions":"Hyponatremia","enrollment":260},{"nctId":"NCT06676774","phase":"PHASE2","title":"Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-05-16","conditions":"Arginine Vasopressin Deficiency, Diabetes Insipidus","enrollment":42},{"nctId":"NCT03446456","phase":"PHASE1, PHASE2","title":"Vasopressin and Pain Perception in the Brain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2018-09-17","conditions":"Acute Pain","enrollment":40},{"nctId":"NCT05467033","phase":"PHASE3","title":"Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2022-09-01","conditions":"Kidney Biopsy","enrollment":424},{"nctId":"NCT06934798","phase":"PHASE4","title":"Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2024-04-01","conditions":"Vasoplegic Syndrome of Cardiac Surgery","enrollment":350},{"nctId":"NCT05293041","phase":"PHASE4","title":"Argipressin's Influence on Blood Loss During Hepatic Resection","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2022-03-27","conditions":"Colon Cancer Liver Metastasis, Inflammatory Response, Vasopressin Causing Adverse Effects in Therapeutic Use","enrollment":248},{"nctId":"NCT06789705","phase":"NA","title":"Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-27","conditions":"Central Diabetes Insipidus","enrollment":24},{"nctId":"NCT06460948","phase":"EARLY_PHASE1","title":"Identifying Oxytocin Deficiency in Adults With Pituitary Disease","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2024-11-13","conditions":"Arginine Vasopressin Deficiency, Oxytocin Deficiency","enrollment":32},{"nctId":"NCT06419075","phase":"PHASE4","title":"Tranexamic Acid in Vaginal Reconstructive Surgery","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2024-07-01","conditions":"Pelvic Organ Prolapse","enrollment":""},{"nctId":"NCT06772584","phase":"NA","title":"Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-01-01","conditions":"Enuresis, Nocturnal","enrollment":90},{"nctId":"NCT04329975","phase":"","title":"Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2020-05-19","conditions":"Nocturia Due to Nocturnal Polyuria","enrollment":1087},{"nctId":"NCT02975999","phase":"PHASE2, PHASE3","title":"Use of Vasopressin Following the Fontan Operation","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-12","conditions":"Pleural Effusion, Single-ventricle","enrollment":12},{"nctId":"NCT05507476","phase":"NA","title":"Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-09-01","conditions":"Anesthesia","enrollment":52},{"nctId":"NCT04950270","phase":"","title":"Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2022-06-18","conditions":"Posterior Reversible Encephalopathy Syndrome","enrollment":24},{"nctId":"NCT06498856","phase":"","title":"Saline Infusion Test in Hyponatremia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2024-07","conditions":"Hyponatremia","enrollment":100},{"nctId":"NCT04420585","phase":"PHASE4","title":"Desmopressin for Bedwetting in Children With SCD","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2020-07-07","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":8},{"nctId":"NCT06285006","phase":"NA","title":"Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2024-02-23","conditions":"Nocturnal Enuresis","enrollment":50},{"nctId":"NCT04103034","phase":"PHASE1","title":"A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers","status":"COMPLETED","sponsor":"Band Therapeutics","startDate":"2019-10-07","conditions":"Cerebrovascular Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis), Intracranial Arteriosclerosis","enrollment":112},{"nctId":"NCT06255366","phase":"PHASE4","title":"Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2024-03-28","conditions":"Lumbar Spondylolisthesis, Arthrosis; Spine","enrollment":126},{"nctId":"NCT05193370","phase":"PHASE4","title":"Angiotensin II vs. Vasopressin in Septic Shock","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-01-03","conditions":"Septic Shock","enrollment":""},{"nctId":"NCT06185361","phase":"NA","title":"Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.","status":"UNKNOWN","sponsor":"Fayoum University Hospital","startDate":"2022-12-01","conditions":"Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal","enrollment":60},{"nctId":"NCT06020456","phase":"","title":"Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A","status":"COMPLETED","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2022-01-01","conditions":"Carrier of Hemophilia A, Desmopressin, Factor VIII Deficiency","enrollment":361},{"nctId":"NCT01982760","phase":"PHASE2","title":"DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2013-12","conditions":"Postoperative Ecchymosis","enrollment":14},{"nctId":"NCT05617664","phase":"NA","title":"Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Benha University","startDate":"2022-11-23","conditions":"Nocturnal Enuresis","enrollment":150},{"nctId":"NCT03389412","phase":"PHASE4","title":"The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-10-01","conditions":"Enuresis, Nocturnal","enrollment":324},{"nctId":"NCT05945420","phase":"PHASE4","title":"Adding Desmopressin to Tamsulosin for Treatment of BPH","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-07-20","conditions":"Nocturnal Polyurea in Patients With BPH","enrollment":160},{"nctId":"NCT05920707","phase":"NA","title":"Common and Differentiated Representations Between Social Exclusion and Social Separation","status":"UNKNOWN","sponsor":"University of Electronic Science and Technology of China","startDate":"2023-04-20","conditions":"Healthy","enrollment":120},{"nctId":"NCT03101826","phase":"NA","title":"Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory","status":"TERMINATED","sponsor":"Indiana University","startDate":"2017-11-01","conditions":"Prader-Willi Syndrome","enrollment":5},{"nctId":"NCT01439997","phase":"PHASE4","title":"Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2012-03-26","conditions":"Nocturia","enrollment":5},{"nctId":"NCT04935814","phase":"PHASE4","title":"Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2021-06-09","conditions":"Major Abdominal Surgery, General Anesthesia, Mechanical Ventilation","enrollment":20},{"nctId":"NCT05628558","phase":"","title":"Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A","status":"UNKNOWN","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2020-07-01","conditions":"Hemophilia A, Mild, Desmopressin, Factor VIII","enrollment":800},{"nctId":"NCT03696121","phase":"PHASE2","title":"Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2019-04-01","conditions":"Stroke, Acute","enrollment":54},{"nctId":"NCT05439460","phase":"PHASE4","title":"Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-01","conditions":"Pulmonary Arterial Hypertension","enrollment":15},{"nctId":"NCT02636387","phase":"","title":"Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2015-08-26","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":14},{"nctId":"NCT05307042","phase":"","title":"Decline in Renal Concentration Ability in Lithium Treated Patients","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2022-05","conditions":"Lithium Toxicities, Bipolar Disorder, Concentration Ability Impaired","enrollment":51},{"nctId":"NCT04394117","phase":"PHASE4","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2020-06-19","conditions":"Coronavirus Disease 2019, COVID-19","enrollment":787},{"nctId":"NCT03201419","phase":"PHASE2","title":"A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-27","conditions":"Nocturia","enrollment":302},{"nctId":"NCT03640949","phase":"PHASE2, PHASE3","title":"Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest","status":"COMPLETED","sponsor":"Lars Wiuff Andersen","startDate":"2018-09-17","conditions":"Heart Arrest","enrollment":501},{"nctId":"NCT03733873","phase":"NA","title":"Study on Chinese and Western Medicine in MNE Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2018-09-01","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":400},{"nctId":"NCT03089073","phase":"","title":"Study of Minirin Melt® in Adult Patients With Nocturia","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-07-13","conditions":"Nocturia","enrollment":835},{"nctId":"NCT04586790","phase":"PHASE2","title":"the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Spinal Shock","enrollment":90},{"nctId":"NCT04545931","phase":"PHASE4","title":"Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"Primary Monosymptomatic Nocturnal Enuresis","enrollment":80},{"nctId":"NCT03088345","phase":"PHASE2, PHASE3","title":"Early Use of Vasopressin in Post-Fontan Management","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2017-03-06","conditions":"Circulatory Perfusion Disorder, Congenital Heart Disease, Single-ventricle","enrollment":20},{"nctId":"NCT00589134","phase":"NA","title":"The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration","status":"COMPLETED","sponsor":"Yale University","startDate":"2006-01","conditions":"Exercise Induced Hyponatremia","enrollment":26},{"nctId":"NCT03379974","phase":"PHASE4","title":"Exercise Versus DDAVP in Patients With Mild Hemophilia A","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2018-07-31","conditions":"Hemophilia A","enrollment":32},{"nctId":"NCT01247090","phase":"PHASE2","title":"Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease","status":"COMPLETED","sponsor":"Columbia University","startDate":"2010-10","conditions":"Hypertension, End Stage Renal Disease","enrollment":12},{"nctId":"NCT04113005","phase":"EARLY_PHASE1","title":"Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-10-01","conditions":"Castrate Resistance Prostate Cancer","enrollment":10},{"nctId":"NCT02905682","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":190},{"nctId":"NCT02904759","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":342},{"nctId":"NCT01611935","phase":"PHASE2","title":"AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-05-01","conditions":"Traumatic Shock","enrollment":101},{"nctId":"NCT03676361","phase":"PHASE4","title":"To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2018-08-29","conditions":"Kidney Damage","enrollment":""},{"nctId":"NCT03167320","phase":"","title":"Low Von Willebrand in Ireland Cohort Study","status":"UNKNOWN","sponsor":"St. James's Hospital, Ireland","startDate":"2014-10","conditions":"Von Willebrand Factor, Deficiency","enrollment":400},{"nctId":"NCT03536910","phase":"NA","title":"Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2018-05-01","conditions":"Fetal Distress","enrollment":60},{"nctId":"NCT01318278","phase":"NA","title":"Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-03","conditions":"Hypotension","enrollment":70},{"nctId":"NCT01036841","phase":"PHASE4","title":"Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2009-12","conditions":"Enuresis, Polyuria","enrollment":24},{"nctId":"NCT02584231","phase":"PHASE4","title":"Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population","status":"COMPLETED","sponsor":"University Ghent","startDate":"2015-09-09","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":25},{"nctId":"NCT03590873","phase":"NA","title":"The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients","status":"UNKNOWN","sponsor":"Hangang Sacred Heart Hospital","startDate":"2018-07-25","conditions":"Burn Surgery","enrollment":158},{"nctId":"NCT02506023","phase":"PHASE1","title":"Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-07","conditions":"Hemophilia A","enrollment":2},{"nctId":"NCT01328561","phase":"","title":"Oxytocin and Arginine Vasopressin in Pain Relief","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2011-03-17","conditions":"Placebo Analgesia","enrollment":167},{"nctId":"NCT01348035","phase":"","title":"Efficacy Study of Water Drinking on PKD Progression.","status":"COMPLETED","sponsor":"Kyorin University","startDate":"2011-04","conditions":"Autosomal Dominant Polycystic Kidney Disease, Disease Progression","enrollment":30},{"nctId":"NCT03136003","phase":"PHASE4","title":"DDAVP vs. Exercise in Patients With Mild Hemophilia A","status":"UNKNOWN","sponsor":"The Hospital for Sick Children","startDate":"2017-07-04","conditions":"Mild Haemophilia A Without Inhibitor","enrollment":30},{"nctId":"NCT03343418","phase":"PHASE4","title":"Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery","status":"UNKNOWN","sponsor":"Instituto do Coracao","startDate":"2015-02","conditions":"C.Surgical Procedure; Cardiac, Blood Coagulation Disorders","enrollment":108},{"nctId":"NCT01327027","phase":"PHASE1","title":"Vasopressin Effects on Human Social Communication","status":"COMPLETED","sponsor":"Bowdoin College","startDate":"2011-09","conditions":"Healthy","enrollment":225},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT01623206","phase":"PHASE2","title":"Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding","status":"COMPLETED","sponsor":"Laboratorio Elea Phoenix S.A.","startDate":"2013-04","conditions":"Colorectal Cancer, Rectal Bleeding","enrollment":30},{"nctId":"NCT01552343","phase":"PHASE3","title":"Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2012-03","conditions":"Nocturia","enrollment":56},{"nctId":"NCT02125188","phase":"PHASE4","title":"Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"Tao Zhang","startDate":"2014-01","conditions":"Patients Undergoing Endoscopic Sinus Surgery","enrollment":60},{"nctId":"NCT02223429","phase":"NA","title":"Neurobiological Bases of Paternal Nurturance","status":"COMPLETED","sponsor":"James K. Rilling, PhD","startDate":"2014-08","conditions":"Healthy","enrollment":35},{"nctId":"NCT02368730","phase":"","title":"Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-06","conditions":"Platelet Dysfunction","enrollment":23},{"nctId":"NCT01994330","phase":"PHASE4","title":"Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2009-06","conditions":"Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis, Heye´s Syndrome, Severe Aortic Stenosis","enrollment":13},{"nctId":"NCT00358579","phase":"PHASE3","title":"Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2006-03","conditions":"Cardiac Arrest","enrollment":727},{"nctId":"NCT01687894","phase":"","title":"Vasopressin to Prevent Hypotension During Beach Chair Surgery","status":"COMPLETED","sponsor":"Chonnam National University Hospital","startDate":"2012-05","conditions":"Rotator Cuff Tear Arthropathy","enrollment":74},{"nctId":"NCT02262936","phase":"PHASE2, PHASE3","title":"Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2015-07","conditions":"Nocturia","enrollment":4},{"nctId":"NCT02937896","phase":"NA","title":"Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2015-01","conditions":"Renal Colic","enrollment":40},{"nctId":"NCT02675868","phase":"PHASE4","title":"Effects of Vasopressors on Immune Response","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2016-01","conditions":"Endotoxemia","enrollment":40},{"nctId":"NCT02084797","phase":"NA","title":"V2 Receptor Effects on Fluid Regulation and Performance","status":"COMPLETED","sponsor":"Oakland University","startDate":"2011-06","conditions":"Electrolyte Imbalance, Hyponatremia, Hypernatremia","enrollment":10},{"nctId":"NCT02626832","phase":"NA","title":"Regulation of Arginine-vasopressin (AVP)","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-02","conditions":"Schizophrenia, Depression","enrollment":25},{"nctId":"NCT00477490","phase":"PHASE3","title":"Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-05","conditions":"Nocturia","enrollment":799},{"nctId":"NCT00337766","phase":"PHASE4","title":"Desmopressin in Cardiac Surgery","status":"COMPLETED","sponsor":"Università Vita-Salute San Raffaele","startDate":"2006-06","conditions":"Hemorrhage, Blood Loss, Surgical, Postoperative Hemorrhage","enrollment":""},{"nctId":"NCT01262456","phase":"PHASE3","title":"Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-02","conditions":"Nocturia","enrollment":395},{"nctId":"NCT01223937","phase":"PHASE3","title":"Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-11","conditions":"Nocturia","enrollment":268}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Arginine Vasopressin"],"phase":"marketed","status":"active","brandName":"Vasopressin, Arginine","genericName":"Vasopressin, Arginine","companyName":"Lars Wiuff Andersen","companyId":"lars-wiuff-andersen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Arginine vasopressin is a peptide hormone that binds to vasopressin receptors to increase blood pressure, promote water reabsorption in the kidneys, and enhance blood clotting. Used for Variceal bleeding (esophageal varices), Diabetes insipidus, Hypotension/shock.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}